TNFα production is associated with dyslipidemia in many metabolic disorders (atherosclerosis, insulin resistance, obesity, and diabetes) and in cardiovascular disease (reviewed in [25, 26, 56–58]). This evidence concerns the gene TNF and metabolic syndrome.